Nazila Bahmaie | Immunology and Microbiology | Best Researcher Award

Posted on by ScienceFather

Dr. Nazila Bahmaie | Immunology and Microbiology | Best Researcher Award

clinical research assistant at Ankara Yildirim Beyazit University, Turkey

Nazila Bahmaie is a dedicated researcher and PhD candidate specializing in Cancer Biology. Born in Ahvaz, Iran, on December 21, 1990, she has pursued an academic and research career across multiple countries, including Iran, Cyprus, and Turkey. Currently enrolled at Ankara Yildirim Beyazit University in Turkey, Nazila is focused on advancing her expertise in cancer biology. Her international academic experience has allowed her to engage with diverse research methodologies, enhancing her scientific adaptability. With a deep commitment to biomedical research, she aims to contribute to groundbreaking discoveries in cancer treatment and immunology. Nazila’s extensive background in medical sciences reflects her passion for understanding complex biological processes and her dedication to improving global healthcare outcomes.

Professional Profile

Education

Nazila Bahmaie has an impressive academic background, with degrees in cellular and molecular biology, medical microbiology, and immunology. She completed her BSc in Cellular and Molecular Biology, majoring in Microbiology, at Maragheh University in Iran, followed by an MSc in Medical Microbiology and Immunology at Zanjan University of Medical Sciences, where she graduated with distinction. Continuing her academic journey, she pursued a PhD in Immunology and Allergy at Near East University in Cyprus before transferring to her current PhD program in Cancer Biology at Ankara Yildirim Beyazit University in Turkey. Her educational trajectory demonstrates a consistent focus on biology and medical sciences, with an emphasis on translational research that bridges basic science and clinical applications.

Professional Experience

Nazila Bahmaie’s professional journey includes significant research roles in cancer biology, immunology, and medical microbiology. As a PhD candidate at Ankara Yildirim Beyazit University, she conducts cancer research under the guidance of prominent scientists, focusing on cancer biology and immunological mechanisms. Before this, she contributed to the field of immunology during her PhD fellowship at Near East University, where she explored pediatric immunology and allergy. Nazila has also worked in medical microbiology, conducting essential research during her MSc studies at Zanjan University of Medical Sciences. Her professional experiences have equipped her with diverse research skills, including cellular and molecular techniques, and a deep understanding of immune responses in diseases.

Research Interests

Nazila Bahmaie’s research interests are focused on the intersection of cancer biology and immunology, particularly in understanding the molecular mechanisms that drive cancer progression and how the immune system can be leveraged to treat cancers. She is deeply involved in studying the immune responses in cancer patients and exploring innovative immunotherapy approaches that could lead to more effective treatments. Her background in microbiology also informs her interest in how microbial infections can influence immune regulation and cancer development. Nazila aims to contribute to the development of targeted therapies that enhance the body’s immune response against tumors, making her research both translational and clinically relevant.

Awards and Honors

Nazila Bahmaie has consistently excelled throughout her academic career, earning high honors and recognition for her academic performance. She graduated with distinction during her MSc in Medical Microbiology and Immunology, earning an A++ for her academic achievements at Zanjan University of Medical Sciences. In addition, she successfully secured a PhD fellowship in Immunology and Allergy at Near East University, showcasing her dedication and merit in the field. While specific awards and honors related to her current PhD work are not detailed, her academic trajectory and continuous involvement in research highlight her potential for future recognition in the scientific community, particularly in cancer biology and immunology.

Conclusion

Nazila Bahmaie has a solid academic foundation and promising potential, particularly in the fields of cancer biology and immunology. However, to be a strong contender for the Best Researcher Award, she would benefit from expanding her publication portfolio, demonstrating a clear impact of her research, and engaging in leadership roles. If she addresses these areas, she could emerge as a notable candidate in future award cycles.

Publication top noted

  • 📄 47D11 Antibody-Engineered Exosomes for Targeted Delivery of Remdesivir in Patients with COVID-19: Dream or Principle? (A Critical Editorial Study)
    • Authors: Daneshi, N., Esmaeilzadeh, A., Bahmaie, N.
    • Journal: Eurasian Journal of Medicine
    • Year: 2022
    • Citations: 1
  • 📄 Cell-Free Treatments: A New Generation of Targeted Therapies for Treatment of Ischemic Heart Diseases
    • Authors: Daneshi, N., Bahmaie, N., Esmaeilzadeh, A.
    • Journal: Cell Journal
    • Year: 2022
    • Citations: 3
  • 📄 Immunobiological Properties and Clinical Applications of Interleukin-38 for Immune-Mediated Disorders: A Systematic Review Study
    • Authors: Esmaeilzadeh, A., Bahmaie, N., Nouri, E., Hajkazemi, M.J., Rafie, M.Z.
    • Journal: International Journal of Molecular Sciences
    • Year: 2021
    • Citations: 8
  • 📄 The Clinical Efficacy of Rituximab Administration in Autoimmunity Disorders, Primary Immunodeficiency Diseases and Malignancies
    • Authors: Zian, Z., Berry, S.P.D.-G., Bahmaie, N., Khan, H., Azizi, G.
    • Journal: International Immunopharmacology
    • Year: 2021
    • Citations: 5
  • 📄 Clinical Applications of Interleukin-37: A Key Player in the Immunopathogenesis of Immune Disorders
    • Authors: Khosh, E., Bahmaie, N., Elahi, R., Esmaeilzadeh, A.
    • Journal: Iranian Journal of Allergy, Asthma and Immunology
    • Year: 2020
    • Citations: 2

 

Khalid Abd El Ghany | signal processing | Best Researcher Award

Posted on by ScienceFather

Khalid Abd El Ghany | Microbial biotechnology | Best Researcher Award

Assistant Professor at Egyption Drug Authoriity, Egypt.

Khalid Abd El Ghany is a distinguished researcher and pharmaceutical professional based in Giza, Egypt. With a strong academic foundation in pharmacy and biotechnology, he has dedicated his career to advancing the pharmaceutical sector through rigorous research and practical applications. As the Post-Approval Control Manager at the Egyptian Drug Authority, Khalid plays a critical role in ensuring the safety and efficacy of pharmaceutical products. His leadership in various charitable organizations and professional boards underscores his commitment to community service and professional excellence. Recognized for his outstanding contributions to the field, Khalid’s blend of research expertise, management skills, and a passion for innovation make him a strong candidate for the Best Researcher Award.

Profile👤

Google Scholar

Education📝

Khalid Abd El Ghany holds a B.Sc. degree with honors in Pharmacy from Al-Azhar University, Egypt, earned in 1994. He furthered his studies by obtaining a Master’s degree in Microbial Biotechnology from Al-Sadat City University between 2012 and 2014. Khalid completed his Ph.D. in the same field at Al-Sadat City University in 2018, focusing on genetic engineering and biotechnology. His dedication to continuous learning is evident through his post-doctoral research role at the Egyptian Drug Authority, which he began in 2020. Khalid has also participated in various professional training courses, including project management and advanced microbial identification workshops. This extensive education equips him with a deep understanding of pharmaceutical sciences, making him well-prepared for his current roles in research and regulation.

Experience👨‍🏫

Khalid Abd El Ghany has a wealth of experience in the pharmaceutical industry, spanning over two decades. Since 2021, he has served as the Post-Approval Control Manager at the Egyptian Drug Authority, where he oversees the evaluation of pharmaceutical products to ensure compliance with regulatory standards. Prior to this, he was the Deputy Head of the Inspection Department at NODCAR from 2017 to 2021 and worked in the Inspection Department with a focus on microbiology from 2012 to 2017. Khalid began his career as a pharmacist at the Arab Drug Company in 1995, gradually advancing through various roles in the private pharmaceutical sector until 2011. His extensive experience in regulatory affairs, inspection, and quality assurance positions him as a key player in enhancing pharmaceutical safety and efficacy in Egypt.

Research Interest🔬 

Khalid Abd El Ghany’s research interests primarily focus on microbial biotechnology, genetic engineering, and drug safety. His academic and professional pursuits are driven by a desire to innovate within the pharmaceutical field, particularly in the development and approval of microbial-based products. Khalid is keen on exploring new methodologies for enhancing drug efficacy and safety, with a specific interest in post-approval monitoring and control processes. His work aims to bridge the gap between laboratory research and practical applications, ensuring that pharmaceuticals meet the highest safety standards. Additionally, Khalid’s ongoing research contributes to advancing knowledge in the biotechnology sector, emphasizing the importance of regulatory compliance in drug development.

Awards and Honors🏆

Khalid Abd El Ghany has received several prestigious awards and honors in recognition of his contributions to the pharmaceutical field. In 2022, he was awarded the Egyptian Drug Authority Hero’s Certificate for his exceptional service and dedication to improving drug safety in Egypt. Previously, in 2016, he was recognized as the Ideal Pharmacist by the Syndicate, highlighting his commitment to excellence in pharmaceutical practice. His involvement in various professional boards and organizations, including the Charity Society and the Takaful Fund, further demonstrates his leadership and commitment to community welfare. These accolades not only acknowledge his professional achievements but also reflect his passion for advancing the pharmacy profession and improving public health.

Skills🛠️

Khalid Abd El Ghany possesses a diverse skill set that enhances his effectiveness as a researcher and pharmaceutical manager. He is proficient in advanced Microsoft Office applications and SPSS, which are essential for data analysis and presentation in research. His experience in regulatory affairs has equipped him with a thorough understanding of compliance standards, ensuring that pharmaceutical products meet safety and efficacy requirements. Khalid’s training in project management and microbial identification further strengthens his ability to lead research initiatives and manage complex projects. Additionally, his strong communication skills enable him to collaborate effectively with multidisciplinary teams and share research findings with various stakeholders. His ongoing commitment to professional development ensures that he remains at the forefront of advancements in the pharmaceutical and biotechnology sectors.

Conclusion 🔍 

In conclusion, Khalid Abd El Ghany is a highly qualified candidate for the Best Researcher Award, with a proven track record in pharmaceutical research and regulatory affairs. His extensive education, coupled with significant experience in various leadership roles, positions him as an influential figure in the field of microbial biotechnology. Khalid’s dedication to advancing drug safety and efficacy, along with his commitment to community service, reflects his passion for improving public health. His numerous accolades underscore his contributions to the pharmaceutical profession, making him a role model for aspiring researchers. With a focus on continuous learning and innovation, Khalid is well-equipped to make further significant impacts in the field, aligning perfectly with the values of the Best Researcher Award.

Publication Top Notes

Title: A potential role of Lactobacillus acidophilus LA1 and its exopolysaccharides on cancer cells in male albino mice
Authors: HAH Khalid Abd El Ghany, Ragaa Hamouda, Ekbal Abd Elhafez, Hoda Mahrous
Year: 2015
Cited by: 43

Title: In Silico Designing of a Multitope Vaccine against Rhizopus microsporus with Potential Activity against Other Mucormycosis Causing Fungi
Authors: Khalid Abd El Ghany et al.
Year: 2021
Cited by: 26

Title: Evaluation of antioxidant and antitumor activities of Lactobacillus acidophilus bacteria isolated from Egyptian infants
Authors: KA El-Ghany, EA Elhafez, RA Hamouda, H Mahrous, FAH Ahmed et al.
Year: 2014
Cited by: 20

Title: Screening and molecular identification of lactic acid bacteria producing β-glucan in boza and cider
Authors: SA Allaith, ME Abdel-Aziz, ZA Thabit, AB Altemimi, K Abd El-Ghany et al.
Year: 2022
Cited by: 13

Title: Description of isolated LAB producing β-glucan from Egyptian sources and evaluation of its therapeutic effect
Authors: KA El-Ghany, RA Hamouda, H Mahrous, EA Elhafez, FAH Ahmed et al.
Year: 2016
Cited by: 11

Title: Integration of Immunoinformatics and Cheminformatics to Design and Evaluate a Multitope Vaccine against Klebsiella pneumoniae and Pseudomonas aeruginosa Coinfection
Authors: AM Gouda, MA Soltan, K Abd El Ghany, AE Sileem, HM Elnahas et al.
Year: 2023
Cited by: 5

Title: Molecular Characterization Using gtf Gene Detection and Medium Optimization of Beta-D-Glucan Production from Pediococcus parvulus F1030 Isolated from Local Egyptian Boza
Authors: K Ghany, R Hamouda, H Mahrous, S Sharaf, H Hamza
Year: 2018
Cited by: 3

Title: Lactiplantibacillus plantarum and Saussurea costus as Therapeutic Agents against a Diabetic Rat Model—Approaches to Investigate Pharmacophore Modeling of Human IkB
Authors: MA AlGeffari, D Mansour, O Ahmed-Farid, E Mohamed Yousef et al.
Year: 2023
Cited by: 2

Title: Role of probiotic bacteria against virus pathogenesis: Insight of immunological stimulations and possible defence against COVID-19
Authors: KA Elghany, MMA Moustafa, SA Mohamed, OA Badr et al.
Year: 2024
Cited by: 1

Title: Efficacy of β-glucan extracted from Pediococcus parvulus F1030 in an acute model of diabetes: hindrance of oxidative stress and atherogenic index of pancreatic cell degradation
Authors: R Hamouda, K Abd El Ghany, O Farid, A Saddiq, TM Al-Shaikh et al.
Year: 2022
Cited by: 1

Title: Synthesis, Molecular Docking Studies and ADME Properties of Some New Pyrazolo[1,5-a]pyrimidines as Antimicrobial, and Anticancer Agents
Authors: H Dweedar, H Mahrous, N Sorour, KAE Ghany, HA Aziz
Year: 2023
Cited by: 1

Title: [Thesis Title]
Authors: KI Abd El Ghany
Year: 2014
Cited by: Not Applicable